Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > more insider buying ...

<< Previous

Bullboard Posts

Next >>

Comment by Spirou25on Jan 20, 2021 10:58am

90 Views

Post# 32333441

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:more insider buying ...

MrMugsy wrote:

MrMugsy wrote:

Spirou25 wrote: They were hedged. They didnt save anything.

Very possible - and the $100M loss, where does that number come from ????

At least with my number, I see foreign exchange reversal entries.
Not sure where he's getting his numbers.
Doesn't really matter but to your point ... would expect a good hedging program from these guys.